EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin



Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin



Bioorganic & Medicinal Chemistry 8(10): 2417-2425



Two new aryl azides, (Z)-1-(3'-azido-4'-methoxyphenyl)-2-(3",4",5"-trimethoxyphenyl)ethene 9 and (Z)-1-(4'-azido-3'-methoxyphenyl)-2-(3",4",5"-trimethoxyphenyl)ethene 5, modeled after the potent antitumor, antimitotic agent combretastatin A-4 (CA-4), have been prepared by chemical synthesis as potentially useful photoaffinity labeling reagents for the colchicine site on beta-tubulin. Aryl azide 9, in which the 3'-hydroxyl group of CA-4 is replaced by an azido moiety, demonstrates excellent in vitro cytotoxicity against human cancer cell lines (NCI 60 cell line panel, average GI50 = 4.07 x 10(-8) M) and potent inhibition of tubulin polymerization (IC50 = 1.4+/-0.1 microM). The 4'-azido analogue 5 has lower activity (NCI 60 cell line panel, average GI50 = 2.28 x 10(-6) M, and IC50 = 5.2+/-0.2 microM for inhibition of tubulin polymerization), suggesting the importance of the 4'-methoxy moiety for interaction with the colchicine binding site on tubulin. These CA-4 aryl azide analogues also inhibit binding of colchicine to tubulin, as does the parent CA-4, and therefore these compounds are excellent candidates for photoaffinity labeling studies.

(PDF emailed within 0-6 h: $19.90)

Accession: 047511326

Download citation: RISBibTeXText

PMID: 11058036

DOI: 10.1016/s0968-0896(00)00176-0



Related references

Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents. Bioorganic & Medicinal Chemistry 14(9): 3231-3244, 2006

Synthesis of molecular probes for tubulin based on Combretastatin A-4. Abstracts of Papers American Chemical Society 215(1-2): ORGN 42, 1998

Molecular modeling study, synthesis and biological evaluation of combretastatin A-4 analogues as anticancer agents and tubulin inhibitors. Medchemcomm 9(2): 316-327, 2018

Potential photoaffinity labels for tubulin Synthesis and evaluation of diazocyclohexadienone and azide analogs of colchicine, combretastatin, and 3,4,5-trimethoxybiphenyl. Journal of Organic Chemistry 59(15): 4285-4296, 1994

Synthesis and biological evaluation of (1-aryl-1H-pyrazol-4-yl) (3,4,5-trimethoxyphenyl)methanone derivatives as tubulin inhibitors. European Journal of Medicinal Chemistry 156: 137-147, 2018

Imidazolone-amide bridges and their effects on tubulin polymerization in cis-locked vinylogous combretastatin-A4 analogues: synthesis and biological evaluation. Bioorganic & Medicinal Chemistry 19(11): 3579-3584, 2011

Synthesis and biological evaluation of arylcinnamide linked combretastatin-A4 hybrids as tubulin polymerization inhibitors and apoptosis inducing agents. Bioorganic & Medicinal Chemistry Letters 26(12): 2957-2964, 2016

Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4. Bioorganic & Medicinal Chemistry Letters 22(23): 7227-7231, 2013

Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives. Organic & Biomolecular Chemistry 3(14): 2657-2660, 2005

Triarylethylene ligands which incorporate structural motifs reminiscent of combretastatin A-4 and tamoxifen Synthesis and biological evaluation as tubulin binding compounds. Abstracts of Papers American Chemical Society 222(1-2): MEDI68, 2001

1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. Bioorganic & Medicinal Chemistry 16(9): 4829-4838, 2008

Synthesis and In Vitro Biological Activity Evaluation of the Derivatives of Combretastatin A-4. Letters in Drug Design & Discovery 3(8): 544-546, 2006

New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation. Bioorganic & Medicinal Chemistry 13(11): 3853-3864, 2005

Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents. European Journal of Medicinal Chemistry 144: 817-842, 2018

Design, synthesis, biological evaluation, and structure-activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new tubulin inhibitors mimicking combretastatin A-4. Journal of Medicinal Chemistry 54(13): 4559-4580, 2011